Delivery Order SPE2DB22D3011-SPE2DB24FP9AW
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of INBRIJA 42 MG Inhalation Capsules. The $1,876.50 firm-fixed-price delivery order is not designated as a set-aside contract. The award falls under a broader Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for the supply of a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,251.00 firm fixed price delivery order contract to supply INBRIJA 42 MG INHALATION CAP 60S. The award has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not associated with any larger contract vehicles and does not have a set-aside designation. Amerisourcebergen Drug Corp regularly receives similar...
- This is a $1,876.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the...
- This federal contract award, valued at $1,294.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a medical product, with an ultimate completion date of April 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a $1,251.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564542915 INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of May 30, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,251.00 Firm Fixed Price Delivery Order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S, with a completion date of July 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, enabling the company to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,876.50. This contract has a completion date of March 13, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as a prime contractor to DLA Troop Support Medical, providing a range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $2,502 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,694,800 INBRIJA 42 MG INHALATION CAP 60S. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
- This federal contract award, valued at $1,294.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a completion date of February 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9AWDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $1,251.00, is for the supply of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. This award does not have a set-aside designation. The delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to support Department of Defense military treatment programs and facilities worldwide. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering the contracted products and services from its Corporate Office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/6/24 |